알레르기성 비염 시장 규모, 점유율, 성장 분석 : 유형별, 치료별, 투여 경로별, 제형별, 검사법별, 유통 채널별, 지역별 - 산업 예측(2025-2032년)
Allergic Rhinitis Market Size, Share, and Growth Analysis, By Type (Seasonal, Perennial), By Treatment (Immunotherapy, Antihistamines), By Route of Administration, By Form, By Test, By Distribution Channel, By Region - Industry Forecast 2025-2032
상품코드:1690007
리서치사:SkyQuest
발행일:2025년 03월
페이지 정보:영문 219 Pages
라이선스 & 가격 (부가세 별도)
한글목차
알레르기성 비염 시장 규모는 2023년에 118억 달러로 평가되며, 2024년 122억 4,000만 달러에서 2032년에는 163억 6,000만 달러로 성장하며, 예측 기간(2025-2032년)의 CAGR은 3.7%로 성장할 전망입니다.
알레르기성 비염 시장은 알레르기 질환의 유병률 증가, 환경 조건의 변화, 치료 옵션에 대한 인식 증가에 의해 주도되고 있습니다. 주요 성장 촉진요인으로는 혁신적인 치료제 개발, 주요 의료비 지출 증가, 보다 효과적인 치료법 발견을 위한 연구 진행 등이 있습니다. 그러나 일반의약품의 가용성 등의 문제가 처방약 판매에 영향을 미치고 있습니다. 이 시장은 대형 제약회사들이 주도하고 있으며, 면역치료 솔루션의 발전에 큰 노력을 기울이고 있습니다. 치료 방법의 지속적인 강화와 맞춤형 의료로의 전환과 같은 긍정적인 추세는 알레르기성 비염의 미래 전망을 형성하고 있습니다. 전반적으로 이 시장은 알레르기 질환에 대한 대응에 있으며, 큰 성장과 혁신의 잠재력을 보여주고 있습니다.
목차
서론
조사의 목적
조사 범위
정의
조사 방법
정보 조달
2차와 1차 데이터 방법
시장 규모 예측
시장의 전제조건과 제한
개요
세계 시장 전망
공급과 수요 동향 분석
부문별 기회 분석
시장 역학과 전망
시장 개요
시장 규모
시장 역학
촉진요인과 기회
억제요인과 과제
Porter의 산업 분석
주요 시장 인사이트
주요 성공 요인
경쟁의 정도
주요 투자 기회
시장 에코시스템
시장의 매력 지수(2024년)
PESTEL 분석
거시경제 지표
밸류체인 분석
가격 분석
규제 상황
사례 연구
기술의 진보
알레르기성 비염 시장 규모 : 유형별 & CAGR(2025-2032)
시장 개요
계절성
연중성
직업성 비염
알레르기성 비염 시장 규모 : 치료별 & CAGR(2025-2032)
시장 개요
면역치료
항히스타민약
충혈 제거약
척추고정술
코르티코스테로이드
기타
알레르기성 비염 시장 규모 : 투여 경로별 & CAGR(2025-2032)
시장 개요
경구
비경구
비강내
알레르기성 비염 시장 규모 : 제형별 & CAGR(2025-2032)
시장 개요
고체
액체
알레르기성 비염 시장 규모 : 검사법별 & CAGR(2025-2032)
시장 개요
피부 테스트
IgE RAST 검사
완전 혈구 계산
알레르기성 비염 시장 규모 : 유통 채널별 & CAGR(2025-2032)
시장 개요
병원 약국
소매 약국
온라인 스토어
알레르기성 비염 시장 규모 & CAGR(2025-2032)
북미
미국
캐나다
유럽
독일
스페인
프랑스
영국
이탈리아
기타 유럽 지역
아시아태평양
중국
인도
일본
한국
기타 아시아태평양
라틴아메리카
브라질
기타 라틴아메리카 지역
중동 및 아프리카
GCC 국가
남아프리카공화국
기타 중동 및 아프리카
경쟁 정보
상위 5사의 비교
주요 기업의 시장 포지셔닝(2024년)
주요 시장 기업이 채택한 전략
최근 시장 동향
기업의 시장 점유율 분석(2024년)
주요 기업의 기업 개요
기업의 상세
제품 포트폴리오 분석
기업의 부문별 점유율 분석
매출의 전년대비 비교(2022-2024)
주요 기업 개요
ALK-Abello A/S(Denmark)
Chiesi Farmaceutici S.p.A.(Italy)
Sun Pharmaceutical Industries Limited(India)
Teva Active Pharmaceutical Ingredients(Israel)
GlaxoSmithKline plc(United Kingdom)
Merck & Co., Inc.(USA)
AstraZeneca plc(United Kingdom)
Novartis International AG(Switzerland)
Pfizer Inc.(USA)
Johnson & Johnson(USA)
Bayer AG(Germany)
Roche Holding AG(Switzerland)
AbbVie Inc.(USA)
Eli Lilly and Company(USA)
Boehringer Ingelheim GmbH(Germany)
Takeda Pharmaceutical Company Limited(Japan)
Mylan N.V.(USA)
Cipla Limited(India)
Dr. Reddy's Laboratories(India)
결론과 제안
KSA
영문 목차
영문목차
Allergic Rhinitis Market size was valued at USD 11.8 billion in 2023 and is poised to grow from USD 12.24 billion in 2024 to USD 16.36 billion by 2032, growing at a CAGR of 3.7% during the forecast period (2025-2032).
The allergic rhinitis market is being propelled by the rising prevalence of allergic disorders, shifting environmental conditions, and heightened awareness of treatment options. Key growth drivers include the development of innovative therapeutics, increasing healthcare expenditures, and ongoing research aimed at discovering more effective treatments. However, challenges such as the availability of over-the-counter medications are affecting prescription sales. The market is dominated by major pharmaceutical companies, with a significant focus on advancing immunotherapy solutions. Positive trends include continuous enhancements in treatment modalities and a shift towards personalized medicine, which are shaping the future of the allergic rhinitis landscape. Overall, the market exhibits considerable potential for growth and innovation in addressing allergic conditions.
Top-down and bottom-up approaches were used to estimate and validate the size of the Allergic Rhinitis market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Allergic Rhinitis Market Segments Analysis
Global Allergic Rhinitis Market is segmented by Type, Treatment, Route of Administration, Form, Test, Distribution Channel and region. Based on Type, the market is segmented into Seasonal, Perennial and Occupational Rhinitis. Based on Treatment, the market is segmented into Immunotherapy, Antihistamines, Decongestants, Vertebral Fusion, Corticosteroids and Others. Based on Route of Administration, the market is segmented into Oral, Parenteral and Intranasal. Based on Form, the market is segmented into Solid and Liquid. Based on Test, the market is segmented into Skin Test, IgE RAST Test and Complete Blood Count. Based on Distribution Channel, the market is segmented into Hospital Pharmacies, Retail Pharmacies and Online Stores. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Allergic Rhinitis Market
The global allergic rhinitis market is significantly propelled by the rising prevalence of the condition, influenced by environmental factors and lifestyle changes. This surge can be attributed to factors such as urbanization, heightened pollution levels, and increased exposure to allergens, all of which contribute to a higher demand for effective treatment solutions. As more individuals experience the discomfort associated with allergic rhinitis, the need for innovative therapies and management strategies is becoming increasingly critical, thereby driving growth within the market and prompting the development of new and enhanced treatments to address this widespread issue.
Restraints in the Allergic Rhinitis Market
A significant restraint in the allergic rhinitis market is the frequent underdiagnosis and undertreatment of the condition, primarily due to limited awareness and misunderstanding of symptoms among both patients and healthcare professionals. This issue is compounded by challenges related to access and affordability of medications, particularly in developing regions, which hinders effective management. Moreover, the complexities of regulatory frameworks and discrepancies in approval processes for allergy medications can impede market growth and the introduction of innovative treatment solutions. Addressing these barriers is essential for enhancing patient outcomes and advancing the overall market for allergic rhinitis.
Market Trends of the Allergic Rhinitis Market
The Allergic Rhinitis market is witnessing a significant shift towards precision medicine and personalized treatment approaches, reflecting an evolving understanding of individual patient profiles and allergen sensitivities. This trend emphasizes tailored interventions, allowing for more effective management of symptoms based on specific characteristics of each patient. Moreover, immunotherapy, particularly through sublingual and subcutaneous methods, is gaining traction as a long-term strategy for altering the disease's trajectory, rather than just managing symptoms. This evolution in treatment methodologies not only enhances patient outcomes but also fosters greater adherence to therapy, thereby driving market growth and innovation in the field of allergic rhinitis management.
Table of Contents
Introduction
Objectives of the Study
Scope of the Report
Definitions
Research Methodology
Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations
Executive Summary
Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis
Market Dynamics & Outlook
Market Overview
Market Size
Market Dynamics
Drivers & Opportunities
Restraints & Challenges
Porters Analysis
Competitive rivalry
Threat of substitute
Bargaining power of buyers
Threat of new entrants
Bargaining power of suppliers
Key Market Insights
Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Landscape
Case Studies
Technological Advancement
Global Allergic Rhinitis Market Size by Type & CAGR (2025-2032)
Market Overview
Seasonal
Perennial
Occupational Rhinitis
Global Allergic Rhinitis Market Size by Treatment & CAGR (2025-2032)
Market Overview
Immunotherapy
Antihistamines
Decongestants
Vertebral Fusion
Corticosteroids
Others
Global Allergic Rhinitis Market Size by Route of Administration & CAGR (2025-2032)
Market Overview
Oral
Parenteral
Intranasal
Global Allergic Rhinitis Market Size by Form & CAGR (2025-2032)
Market Overview
Solid
Liquid
Global Allergic Rhinitis Market Size by Test & CAGR (2025-2032)
Market Overview
Skin Test
IgE RAST Test
Complete Blood Count
Global Allergic Rhinitis Market Size by Distribution Channel & CAGR (2025-2032)
Market Overview
Hospital Pharmacies
Retail Pharmacies
Online Stores
Global Allergic Rhinitis Market Size & CAGR (2025-2032)
North America (Type, Treatment, Route of Administration, Form, Test, Distribution Channel)
US
Canada
Europe (Type, Treatment, Route of Administration, Form, Test, Distribution Channel)
Germany
Spain
France
UK
Italy
Rest of Europe
Asia Pacific (Type, Treatment, Route of Administration, Form, Test, Distribution Channel)
China
India
Japan
South Korea
Rest of Asia-Pacific
Latin America (Type, Treatment, Route of Administration, Form, Test, Distribution Channel)
Brazil
Rest of Latin America
Middle East & Africa (Type, Treatment, Route of Administration, Form, Test, Distribution Channel)
